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Abstract Tyrosyl radicals can catalyze LDL oxidation. In 
addition to their LDL oxidizing ability, Superoxide (02' )/nitric 
oxide (NO) generate phenoxyl radicals when reacting with 
tyrosine. Therefore we tested if tyrosine can act as a pro-oxidant 
in 02 ' /NO'-initiated LDL oxidation. When LDL was exposed 
to 02~/NO', tyrosine exerted a strong inhibitory effect on 0 2 ~ / 
NO'-initiated LDL oxidation as measured by TBARS formation 
and alteration in electrophoretic mobility of LDL. Tyrosine was 
also able to protect human endothelial cells from the cytotoxic 
effect of 02 ' /NO'. Because 02 ' /NO' can occur in vivo, the 
results may indicate that serum-free tyrosine could act as an 
efficacious physiological antioxidant in case of 02 '~/NO-
initiated LDL oxidation and endothelial cell cytotoxicity. 
© 1997 Federation of European Biochemical Societies. 
Key words: LDL oxidation; Superoxide; Nitric oxide; 
Antioxidant; Tyrosine; SIN-1 
1. Introduction 
There is experimental evidence that the oxidative modifica-
tion of LDL plays a pathophysiological role in the onset of 
atherogenesis [1]. This observation has led to studies dealing 
with the inhibition of LDL oxidation by drugs or naturally 
occurring compounds [2-7]. Lipid peroxidation can be initi-
ated by e.g. copper ions, organic peroxyl radicals, hypochlo-
rite and superoxide/nitric oxide radicals (0 2 ~/NO) [8-11]. 
Recently, it has been shown that MPO in presence of H2O2 
and tyrosine was able to generate tyrosyl radicals [12] which 
could act as catalysts for the initiation of LDL oxidation [13]. 
Tyrosyl radicals are also formed when the reaction product 
of 02 '~/NO' reacts with free tyrosine or tyrosine residues in 
proteins resulting in chemical modification of the amino acid 
[14,15]. Taking this and the fact into account that θ2~/ΝΟ' 
can cause lipid peroxidation, one could assume that tyrosine 
may be able to act as a pro-oxidant in the θ2'~/ΝΟ'-initiated 
LDL oxidation. 
We report that tyrosine inhibited the 02'~/NO'-induced lip-
id peroxidation and, in addition, could protect human endo-
thelial cells from the cytotoxic effect of 0 2~/NO' radicals. 
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2. Materials and methods 
Amino acids, 3-nitro-L-tyrosine and 3-morpholinosydnonimine 
(SIN-1) were from Sigma Chemical Co. (St. Louis, MO). 
2.1. LDL isolation 
The isolation of LDL from human plasma followed procedures 
reported previously [16]. The final preparation was filter sterilized 
and stored in 0.15 mol/1 NaCl containing 0.1 mmol/1 EDTA. 
2.2. Lipoprotein oxidation 
LDL (2 mg/ml) was incubated in a total volume of 250 μΐ (0.15 mol/ 
1 NaCl, 0.025 mol/1 TRIS-HCl, pH 7.4) with or without SIN-1 for 18 h 
at 37°C. Lipid peroxidation products were measured as thiobarbituric 
acid reactive substances (TBARS) and expressed as malondialdehyde 
equivalents (MDA) according to [17]. 
2.3. Agarose gel electrophoresis 
Of the treated or untreated LDL, 10-20 μg was analyzed on agar-
ose gels using a commercial system (Lipidophor All In, Immuno AG, 
Vienna, Austria). Measurement of relative electrophoretic mobility 
(REM) was taken as an indicator of LDL oxidation [1,8], setting 
the electrophoretic mobility of native (untreated) LDL arbitrarily as 1. 
2.4. Endothelial cells 
Human umbilical vein endothelial cells (HUVEC) were prepared 
and cultured as previously reported [18]. Cells were seeded in 6-well 
culture plates. After cells had reached confluency the cells were 
washed with phosphate-buffered saline (PBS) and further cultured in 
a medium containing ions and glucose as given for RPMI-1640, but 
without amino acids. 
2.5. Cytotoxicity 
The release of lactate dehydrogenase activity (LDH) into the cell 
culture medium was taken as an indicator of cytotoxicity. LDH ac-
tivity was measured by a commercial test kit (Boehringer Mannheim 
Automated Analysis for BM/Hitachi 717, Germany). 
2.6. Analysis of reaction products 
Reaction mixtures containing LDL (2 mg/ml) and the respective 
compounds (SIN-1, tyrosine, tryptophan) were analyzed by HPLC 
essentially as described by Kaur and Halliwell [19]. 
3. Results 
3.1. LDL oxidation by superoxide/nitric oxide radicals 
LDL was subjected to 02'~/NO'-induced lipid oxidation 
using the sydnonimine SIN-1, which generates simultaneously 
both radical species in solution at 37°C [10]. LDL was incu-
bated for 18 h at 37°C with SIN-1 (up to 5 mmol/1) and 
subsequently the lipoprotein oxidation was measured by 
TBARS formation [10]. A concentration-dependent increase 
of TBARS was observed. However, in the presence of tyrosine 
(2 mmol/1) there were no TBARS formed, that is, no LDL 
oxidation occurred (see Fig. 1A). 
In addition, agarose gel electrophoresis revealed, that the 
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Fig. 1. A: Effect of tyrosine and phenylalanine on SIN-1-induced LDL oxidation. LDL (2 mg/ml) was incubated in the presence or absence of 
SIN-1 for 18 h at 37°C. Parallel incubations were run with tyrosine (2 mmol/1) or phenylalanine (2 mmol/1) and the respective SIN-1 concentra-
tion. LDL oxidation was expressed as TBARS formed as given in Section 2. ■. SIN-1; o, SIN-1 and tyrosine; Δ, SIN-1 and phenylalanine. 
B; Effect of tyrosine on SIN-1-induced changes of LDL electrophoretic mobility. LDL (2 mg/ml) was incubated in the presence or absence of 
SIN-1 for 18 h at 37°C. Parallel incubations were run with tyrosine (2 mmol/1) and the respective SIN-1 concentration. The electrophoretic mo-
bility relative to untreated LDL (REM) was determined as given in Section 2. ■. SIN-1; o, SIN-1 and tyrosine. 
SIN-1 induced increase in REM, which is a further indicator 
of LDL modification was completely inhibited in the presence 
of tyrosine (see Fig. IB). Parallel incubations with phenylala-
nine (2 mmol/1) showed that this aromatic amino acid had no 
influence on the 02"/NO'-induced lipid oxidation (see Fig. 
1A). 
Fig. 2 depicts the effect of increasing tyrosine concentra-
tions on LDL oxidation caused by 1.25 mmol/1 SIN-1. 50% 
inhibition of LDL oxidation was observed at about 125 μιηοΐ/ 
1 tyrosine. The well-known hydrophilic antioxidant ascorbic 
acid [20,21] was effective at about 3 times higher concentra-
tion. 
The products of SIN-1 decomposition have been shown to 
lead to chemical modification, i.e. nitration of tyrosine [14,15]. 
Thus one may assume that tyrosine may act as a scavenger of 
the reactive SIN-1 decomposition products which in the ab-
sence of tyrosine oxidize the lipoprotein. Hence, already 
modified tyrosine should posses less antioxidizing activity 
compared to unmodified tyrosine. As can be seen in Fig. 2, 
when 3-nitrotyrosine was added to the LDL oxidating system, 
this compound was only effective at 2 mmol/1 in inhibiting 
LDL oxidation by CV~/NC)'. From all other amino acids 
tested (histidine, proline, tryptophan, cysteine; 2 mmol/1) tryp-
tophan showed the highest inhibitory activity (66%) of LDL 
oxidation compared to tyrosine (86%). Cysteine known to be 
oxidized by peroxynitrite [22], a reaction product of SIN-1 
decomposition, was less effective in inhibiting LDL oxidation 
(35% inhibition). 
3.2. Endothelial cells 
To test if tyrosine and other amino acids can also counter-
act the membrane lipid oxidizing, cell damaging effect of O2"/ 
NO' [23,24], HUVECs were exposed for 16 h to SIN-1 
(1 mmol/1) and the respective amino acid. Cell morphology 
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Fig. 2. Effect of tyrosine, 3-nitrotyrosine and ascorbic acid on SIN-1-induced LDL oxidation. LDL (2 mg/ml) was incubated with SIN-1 (1.25 
mmol/1) for 18 h at 37°C in the absence or presence of the respective compound. ■, Tyrosine; Δ, 3-nitrotyrosine; O, ascorbic acid. 
(phase contrast microscopy) and LDH release were taken 
as indicators of cytotoxicity. SIN-1 treatment caused a release 
of LDH activity of 105 ±2.0 U/l compared to 7.0 ±3.1 U/l 
for untreated cells. Both, tyrosine and tryptophan when added 
to the culture medium (100 μιηοΐ/ΐ) protected the cells from 
the cytotoxic effect of O2' /NO', that is, LDH release was 
diminished to near-control levels (see Table 1). No effect 
was seen when amino acids alone were added to HUVECs 
(data not shown). All other amino acids tested did not show 
a protective effect against the cell damaging potential of SIN-1 
(Table 1). 
Fig. 3 represents morphology of HTJVEC monolayers after 
an 16 h incubation period with SIN-1 in the absence or pres-
ence of tyrosine and cysteine. SIN-1 led to retraction and 
subsequent detachment of endothelial cells, which was over-
come by tyrosine, but not by cysteine. 
4. Discussion 
The present study suggests that tyrosine (tryptophan) is a 
potent antioxidant in the ( V - /NO' -induced oxidation of 
LDL. Simultaneously produced 02 '~/NO' radicals may form 
peroxynitrous acid (ONOOH) or peroxynitrite (ONOO ), 
which can decompose to OH and 'NO2, capable of oxidizing 
tocopherol and lipids in LDL leading to the atherogenic alter-
ations of the lipoprotein [25-27]. In addition to the lipid ox-
idizing ability of ONOOH, it is known that free tyrosine or 
tyrosine residues in proteins can be modified by ONOOH and 
ONOO , forming nitrotyrosine [28,29]. Taking these observa-
tions into account, free tyrosine may act by scavenging the 
Table 1 
Effect of various amino acids on the SIN-1-induced cytotoxicity on 
HUVEC 
Compound added 
none 
SIN-1 
SIN-1+tyrosine 
SIN-1+tryptophan 
SIN-1+threonine 
SIN-1+lysine 
SIN-1+cystine 
SIN-1+cysteine 
SIN-1+arginine 
SIN-1+serine 
SIN-1 +phenylalanine 
SIN-1+histidine 
SIN-1+proline 
Effect of various amino acids on SIN-1-induced endothelial cell dam-
age as measured by LDH release. HUVECs were exposed for 16 h to 
SIN-1 (1 mmol/1) in the absence or presence of amino acids (100 μτηοΐ/ 
1) at 37°C/5% C02. The release of LDH was taken as an indicator of 
cytotoxicity and measured as given in Section 2. All experiments were 
done in triplicate. Means ± SD are given. 
LDH(U/L) 
7±3.1 
105 ±2.0 
31 ±2.5 
27 ±0.6 
122 ±2.7 
112 ±5.9 
95 ± 2.4 
129 ±6.9 
118 ± 3.1 
114 ±2.7 
120 ±7.4 
140 ±9.0 
144 ±6.8 
Fig. 3. Effect of tyrosine and cysteine on SIN-1 altered endothelial 
cell morphology. HUVECs were exposed for 16 h to SIN-1 
(1 mmol/1) in the absence or presence of amino acids (100 μιηοΐ/ΐ) 
at 37°C/5% CO2. HUVEC monolayers as seen in the phase contrast 
microscope (X100 magnification) were photographed after 16 h of 
incubation in the respective medium. 
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reactive nitrogen and/or oxygen species, thus protecting LDL 
from oxidation. This suggestion was partially sustained by our 
results obtained with nitrotyrosine. In contrast to unmodified 
tyrosine, the nitrated amino acid showed very limited antiox-
idative potential, possibly due to the inability of the already 
nitrated amino acid to scavenge the lipid oxidizing reactive 
decomposition products of SIN-1. However, HPLC analysis 
of LDL/SIN-1/tyrosine and LDL/SIN-1 /tryptophan incuba-
tion mixtures revealed that very low concentrations of ni-
trated amino acid derivatives were formed (results not shown), 
an observation which is in accordance with results of van der 
Vliet et al. [15]. These authors have shown that tyrosine in the 
presence of peroxynitrite or SIN-1 was converted to nitroty-
rosine and dityrosine in low amounts. Thus, reaction mecha-
nisms additional to tyrosine nitration may be responsible for 
the observed effect. The amino acid could scavenge radicals 
forming tyrosyl radicals [30] which can dimerize to dityrosine 
and in that way block the oxidative effect of CV'/NO'. On the 
other hand tyrosyl radical itself may be much less damaging 
than θ2~/ΝΟ'. Phenylalanine, most related to tyrosine, was 
ineffective as antioxidant. Peroxynitrite can hydroxylate phe-
nylalanine to tyrosine as reported by van der Vliet et al. [31] 
and one may speculate that during incubation of LDL/SIN-1/ 
phenylalanine tyrosine may be generated and may inhibit the 
lipid peroxidation process. However, the actual amount of 
tyrosine formed by the reaction of phenylalanine with perox-
ynitrite is very low (5 mmol/1 phenylalanine generate about 
10 μpiιοΐ/ΐ of tyrosines) [31]. This could explain the inability of 
phenylalanine to inhibit LDL peroxidation under the exper-
imental conditions. 
02~/NO' have been shown to oxidize membrane lipids, 
thus exerting cytotoxicity to endothelial cells [23]. Our results 
obtained with HUVECs show that tyrosine (tryptophan) was 
a potent cytoprotective agent for endothelial cells treated with 
O2' /NO'. Free tyrosine can reach plasma levels of about 100 
μιηοΐ/ΐ [32], a concentration which was found to inhibit LDL 
oxidation and cytotoxicity towards endothelial cells by O2"/ 
NO' in our system. 
In summary, our data indicate that tyrosine effectively 
counteracts the LDL modifying and cytotoxic effect of O2"/ 
NO'. Both radical species can occur in vivo and the serum 
concentration of free tyrosine is fairly high, but further studies 
will be required to establish the in vivo antioxidant and cyto-
protective effect of this amino acid. 
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